Date Filed | Type | Description |
10/04/2023 |
4
| Nelms Angela (COO) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Bought 300 shares
@ $1.0499, valued at
$315 Bought 800 shares
@ $1.045, valued at
$836 |
|
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 43,026 options to buy
@ $2.74, valued at
$117.9k
|
|
04/27/2023 |
3
| Spiegel Robert J. (Director) has filed a Form 3 on RenovoRx, Inc. |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| RYAN UNA S (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
10/04/2022 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
10/04/2022 |
4
| Macfarlane K. Angela (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
10/04/2022 |
4
| Diamond David (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
09/21/2022 |
4
| Nelms Angela (COO) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 274,230 options to buy
@ $2.42, valued at
$663.6k
|
|
09/21/2022 |
3
| Nelms Angela (COO) has filed a Form 3 on RenovoRx, Inc. |
07/20/2022 |
3
| Ahlers James M (CFO) has filed a Form 3 on RenovoRx, Inc. |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2022 |
3
| BANK OF THE WEST (10% Owner) has filed a Form 3 on RenovoRx, Inc. |
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/14/2022 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
|
|
03/14/2022 |
4
| Macfarlane K. Angela (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
|
|
03/14/2022 |
4
| Diamond David (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
Granted 9,165 options to buy
@ $3.17, valued at
$29.1k
|
|
03/14/2022 |
4
| Agah Ramtin (Chief Medical Officer) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 21,398 options to buy
@ $3.17, valued at
$67.8k
|
|
03/14/2022 |
4
| Bagai Shaun (CEO) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 48,313 options to buy
@ $3.17, valued at
$153.2k
|
|
10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2021 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 11,154 options to buy
@ $5.91, valued at
$65.9k
|
|
10/05/2021 |
4
| Macfarlane Kirsten Angela (Director) has filed a Form 4 on RenovoRx, Inc.
Txns:
| Granted 11,154 options to buy
@ $5.91, valued at
$65.9k
|
|
10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|